Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

615
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
615
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Panic Disorder01:27

Panic Disorder

925
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
925

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimating the potential number of cases prevented by infant/ toddler immunisation with a MenACWY vaccine.

Vaccine·2024
Same author

Expression of bcl-2 protein in nephroblastomas.

International journal of oncology·2011
Same author

A double-blind trial of captopril or bendrofluazide in newly diagnosed senile hypertension.

Current medical research and opinion·1994
Same author

HIV roundtable. Professional perspectives.

Physician assistant (American Academy of Physician Assistants)·1991
Same author

HIV antibody-positive. A new cause of impairment.

Physician assistant (American Academy of Physician Assistants)·1989
Same author

My brother's keeper: assisting the impaired PA.

Physician assistant (American Academy of Physician Assistants)·1984

Related Experiment Video

Updated: Mar 2, 2026

Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

2.3K

PAs confront "denial disease".

L Hadley

    Physician Assistant (American Academy of Physician Assistants)
    |April 10, 1987
    PubMed
    Summary
    This summary is machine-generated.

    A task force was formed to address chemical dependency among Physician Assistants (PAs). Efforts focused on raising awareness and developing identification and intervention programs for impaired PAs.

    More Related Videos

    Using Retinal Imaging to Study Dementia
    09:17

    Using Retinal Imaging to Study Dementia

    Published on: November 6, 2017

    22.4K
    Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
    11:01

    Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease

    Published on: August 30, 2011

    14.1K

    Related Experiment Videos

    Last Updated: Mar 2, 2026

    Transcranial Pulse Stimulation for Alzheimer's Patients
    06:08

    Transcranial Pulse Stimulation for Alzheimer's Patients

    Published on: April 4, 2025

    2.3K
    Using Retinal Imaging to Study Dementia
    09:17

    Using Retinal Imaging to Study Dementia

    Published on: November 6, 2017

    22.4K
    Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
    11:01

    Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease

    Published on: August 30, 2011

    14.1K

    Area of Science:

    • Medical Professionalism
    • Addiction Medicine
    • Public Health

    Background:

    • Chemical dependency is a significant issue affecting Physician Assistants (PAs).
    • The American Academy of Physician Assistants (AAPA) established a task force to address this problem.
    • There is a need for identification and intervention programs within PA chapters.

    Purpose of the Study:

    • To report on the initial efforts of the Task Force on the Impaired PA.
    • To review the progress made in raising awareness about chemical dependency among PAs.
    • To highlight the importance of support systems and recovery role models for affected PAs.

    Main Methods:

    • Formation of a task force by the AAPA House of Delegates.
    • Review of initiatives undertaken over the past year.
    • Inclusion of first-person accounts from recovering PAs.

    Main Results:

    • The Task Force on the Impaired PA has begun its work.
    • Increased awareness regarding chemical dependency among PAs has been noted.
    • Personal narratives of recovery offer insights and encouragement.

    Conclusions:

    • The AAPA is actively addressing chemical dependency within the PA profession.
    • Continued efforts are needed to support impaired PAs and facilitate recovery.
    • Sharing recovery stories is crucial for destigmatization and support.